These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11595587)

  • 1. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
    Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
    J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
    Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
    Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.
    Greijer AE; Verschuuren EA; Harmsen MC; Dekkers CA; Adriaanse HM; The TH; Middeldorp JM
    J Clin Microbiol; 2001 Jan; 39(1):251-9. PubMed ID: 11136779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and duration of cytomegalovirus immediate early 1 mRNA expression in the blood of renal transplant recipients.
    Goossens VJ; Christiaans MH; Blok MJ; Terporten PH; Sillekens P; Lukacsi A; Van Hooff JP; Bruggeman CA
    J Med Virol; 2004 Jan; 72(1):94-101. PubMed ID: 14635016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
    Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
    J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
    Maine GT; Stricker R; Schuler M; Spesard J; Brojanac S; Iriarte B; Herwig K; Gramins T; Combs B; Wise J; Simmons H; Gram T; Lonze J; Ruzicki D; Byrne B; Clifton JD; Chovan LE; Wachta D; Holas C; Wang D; Wilson T; Tomazic-Allen S; Clements MA; Wright GL; Lazzarotto T; Ripalti A; Landini MP
    J Clin Microbiol; 2000 Apr; 38(4):1476-81. PubMed ID: 10747129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex real-time NASBA for monitoring expression dynamics of human cytomegalovirus encoded IE1 and pp67 RNA.
    Greijer AE; Adriaanse HM; Dekkers CA; Middeldorp JM
    J Clin Virol; 2002 Feb; 24(1-2):57-66. PubMed ID: 11744429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study comparing cytomegalovirus antigenemia, DNAemia and RNAemia tests in guiding pre-emptive therapy in thoracic organ transplant recipients.
    Lehto JT; Lemström K; Halme M; Lappalainen M; Lommi J; Sipponen J; Harjula A; Tukiainen P; Koskinen PK
    Transpl Int; 2005 Dec; 18(12):1318-27. PubMed ID: 16297050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
    Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
    J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of CMV early and late transcript detection with NASBA in bronchoalveolar lavages.
    Keightley MC; Rinaldo C; Bullotta A; Dauber J; St George K
    J Clin Virol; 2006 Dec; 37(4):258-64. PubMed ID: 16978918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
    Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
    Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of serology assays and polymerase chain reaction for the monitoring of active cytomegalovirus infection in renal transplant recipients.
    Naumnik B; Małyszko J; Chyczewski L; Kovalchuk O; Małyszko J; Myśliwiec M
    Transplant Proc; 2007 Nov; 39(9):2748-50. PubMed ID: 18021976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women.
    Daiminger A; Bäder U; Eggers M; Lazzarotto T; Enders G
    J Clin Virol; 1999 Aug; 13(3):161-71. PubMed ID: 10443792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CMV transcripts for monitoring of CMV infections in transplant recipients.
    Gerna G; Baldanti F; Middeldorp J; Lilleri D
    Int J Antimicrob Agents; 2000 Dec; 16(4):455-60. PubMed ID: 11118857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.
    Rautenberg P; Lübbert C; Weers W; Boetel E; Schweichler J; Zhou L; Costard-Jäckle A; Kraemer-Hansen H; Harder TC
    J Clin Virol; 1999 Jun; 13(1-2):81-94. PubMed ID: 10405895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
    van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.
    Carbone J; Lanio N; Gallego A; Kern F; Navarro J; Muñoz P; Alonso R; Catalán P; Fernández-Yáñez J; Palomo J; Ruiz M; Fernández-Cruz E; Sarmiento E
    J Clin Immunol; 2012 Aug; 32(4):809-19. PubMed ID: 22371292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.